Mercury Medical’s exclusive distribution agreement with Flat Medical represents a strategic alignment aimed at advancing patient safety and procedural accuracy in U.S. anesthesia care. The decision to partner was driven by the shared commitment to delivering high-impact, clinically validated technologies to frontline providers. As anesthesia-related procedures—particularly epidurals—continue to be widely utilized in labor, surgical, and chronic pain settings, the need for innovation that enhances accuracy and reduces complications has become paramount. The EpiFaith® Smart Syringe addresses this directly by transforming the subjective loss-of-resistance technique into an objective, visually guided method for identifying the epidural space.
This partnership brings clear advantages to clinicians and patients alike. The EpiFaith Smart Syringe offers a hands-free, pressure-sensing solution that improves needle control, reduces the likelihood of accidental dural punctures, and enhances procedural confidence. With Mercury Medical’s well-established presence across hospitals, surgical centers, and critical care environments, the EpiFaith technology can now be scaled more effectively across the U.S. market. The tool is especially valuable in high-stakes environments like obstetric anesthesia and interventional pain management, where procedural errors can have lasting consequences and demand reliable, intuitive solutions.
As the U.S. healthcare system increasingly prioritizes patient safety, standardization, and data-supported innovation, smart devices like EpiFaith are expected to drive meaningful growth in the anesthesia technology segment. With thousands of successful placements globally and endorsements from organizations like Vizient and Premier Inc., EpiFaith has already demonstrated clinical and commercial traction. This agreement not only expands access to a critical safety innovation but also positions both Mercury Medical and Flat Medical to shape the future of intelligent, minimally invasive anesthetic procedures. The partnership is well-timed to meet rising procedural volumes and clinician demand for advanced, user-friendly tools that support better outcomes and long-term market expansion.
MedTech spectrum's Summary
Enhanced Patient Safety and Accuracy: The EpiFaith® Smart Syringe revolutionizes epidural procedures by providing an objective visual confirmation of needle placement, reducing the risk of complications such as accidental dural puncture and improving clinical confidence.
Strategic Market Expansion: Through its nationwide hospital network and established critical care expertise, Mercury Medical will accelerate the adoption of EpiFaith across the U.S., making advanced epidural safety technology more accessible to anesthesia providers.
Future-Driven Innovation: Backed by industry awards and growing global usage, this partnership positions both companies at the forefront of intelligent anesthesia care, addressing a critical clinical need and paving the way for future growth in the smart procedural devices market.
